Novartis AG Total Liabilities 2010-2024 | NVS

Prices Revenue & Profit Assets & Liabilities Margins Price Ratios

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novartis AG total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Novartis AG total liabilities for the quarter ending June 30, 2024 were $55.603B, a 5.83% decline year-over-year.
Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
Novartis AG total liabilities for 2022 were $58.03B, a 9.29% decline from 2021.
Novartis AG total liabilities for 2021 were $63.973B, a 10.04% decline from 2020.

Prices Revenue & Profit Assets & Liabilities Margins Price Ratios

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novartis AG total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Novartis AG total liabilities for the quarter ending June 30, 2024 were $55.603B, a 5.83% decline year-over-year.
Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
Novartis AG total liabilities for 2022 were $58.03B, a 9.29% decline from 2021.
Novartis AG total liabilities for 2021 were $63.973B, a 10.04% decline from 2020.